TGFB1 and Hepatic fibrosis: Earlier studies revealed that treatment with the RXR ligand 9cRA induced fibrinolytic-mediated activation of TGF-β, promoting collagen synthesis and inhibiting its degradation, thereby exacerbating liver fibrosis (Okuno et al., 1997).